LENZ Therapeutics
Del Mar
About LENZ Therapeutics
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes. Its program is an aceclidine-based eye drop designed to restore the loss of near vision associated with presbyopia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $217.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2024)
- Ticker: nasdaq:LENZ
- Website: lenz-tx.com
- Phone: (619)890-5125
Industries & Categories
Health Care, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/lenz-therapeutics-50956 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.